Advanced search
Publication Cover
Nanotoxicology Volume 5, 2011 - Issue 4
Submit an article Journal homepage
154
Views
11
CrossRef citations to date
0
Altmetric
Research Article

Gold nanoparticle trafficking of typically excluded compounds across the cell membrane in JB6 Cl 41-5a cells causes assay interference

Athena M. Keene Center for Drug Evaluation and Research, Food and Drug Administration, Silver Spring, Maryland, USA
,
Robert J. Allaway Center for Drug Evaluation and Research, Food and Drug Administration, Silver Spring, Maryland, USA
,
Nakissa Sadrieh Center for Drug Evaluation and Research, Food and Drug Administration, Silver Spring, Maryland, USA
&
Katherine M. Tyner Center for Drug Evaluation and Research, Food and Drug Administration, Silver Spring, Maryland, USACorrespondence[email protected]
Pages 469-478 | Received 04 Aug 2010, Accepted 18 Oct 2010, Published online: 19 Nov 2010

References

  • Cho WS, Cho M, Jeong J, Choi M, Cho HY, Han BS, 2009. Acute toxicity and pharmacokinetics of 13 nm-sized PEG-coated gold nanoparticles. Toxicol Appl Pharmacol 236:16–24.
  • Darzynkiewicz Z, Juan G, Li X, Gorczyca W, Murakami T, Traganos F. 1997. Cytometry in cell necrobiology: Analysis of apoptosis and accidental cell death (necrosis). Cytometry 27:1–20.
  • Dobrovolskaia MA, Aggarwal P, Hall JB, McNeil SE. 2008a. Preclinical studies to understand nanoparticle interactions with the immune system and its potential effects on nanoparticle biodistribution. Mol Pharm 4:487–495.
  • Dobrovolskaia MA, Clogston JD, Neun BW, Hall JB, Patri AK, McNeil SE. 2008b. Method for analysis of nanoparticle hemolytic properties in vitro. Nano Lett 8:2180–2187.
  • Dobrovolskaia MA, Germolec DR, Weaver JL. 2009. Evaluation of nanoparticle immunotoxicity. Nature Nanotech 4:411–414.
  • Cumberland SL, Strousse GF. 2001. Synthesis and characterization of metal-semiconductor nano-composites. 2001. Mater Res Soc Symp Proc 642: J7.8.1–6.
  • Kroll A, Pillukat MH, Hahn D, Schnekenburger J. 2009. Current in vitro methods in nanoparticle risk assessment: Limitations and challenges. Eur J Pharm Biopharm 72:370–377.
  • Laaksonen T, Santos H, Vihola H, Salonen J, Riikonen J, Heikkila T, Peltonen L, Kuman N, Murzin DY, Lehto VP, Hirvonen J. 2007. Failure of MTT as a toxicity testing agent for mesoporous silicon microparticles. Chem Res Toxicol 20:1913–1918.
  • Leff DV, Brandt L, Heath JR. 1996. Synthesis and characterization of hydrophobic, organically-soluble gold nanocrystals functionalized with primary amines. Langmuir 12:4723–4730.
  • Marquis BJ, Love SA, Braun KL, Haynes CL. 2009. Analytical methods to assess nanoparticle toxicity. Analyst 134:425–439.
  • Monteiro-Riviere NA, Inman AO. 2006. Challenges for assessing carbon nanomaterial toxicity to the skin. Carbon 44:1070–1078.
  • Monteiro-Riviere NA, Inman AO, Zhang LW. 2009. Limitations and relative utility of screening assays to assess engineered nanoparticle toxicity in a human cell line. Toxicol Appl Pharmacol 234:222–235.
  • Shukla S, Pricilla A, Banerjee M, Bhonde RR, Ghatak J, Satyam PV, Sastry M. 2005. Porous gold nanospheres by controlled transmetalation reaction: A novel material for application in cell imaging. Chem Mater 17:5000–5005.
  • Stone V, Johnston H, Schins RPF. 2007. Development of in vitro systems for nanotoxicology: Methodological considerations. Crit Rev Toxicol 39:613–626.
  • Studart AR, Amstad E, Gauckler LJ. 2007. Colloidal stabilization of nanoparticles in concentrated suspensions. Langmuir 23:1081–1090.
  • Uboldi C, Bonacchi D, Lorenzi G, Hermanns MI, Pohl, C, Baldi G, Unger RE, Kirkpatrick CJ. 2009. Gold nanoparticles induce cytotoxicity in the alveolar type-II cell lines A549 and NCIH441. Part. Fibre Toxicol 6:18 (DOI: 10.1186/1743-8977-6-18).
  • Worle-Knirsch JM, Pulskamp K, Krug HF. 2006. Oops they did it again! Carbon nanotubes hoax scientists in viability assays. Nano Lett 6:1261–1268.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.